Actively Recruiting

Phase 4
Age: 18Years - 85Years
All Genders
NCT07210281

Osteogenon in Orthopedics and Traumatology

Led by University of Opole · Updated on 2025-11-28

150

Participants Needed

1

Research Sites

164 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aim of this study was to evaluate the supportive effect of the ossein-hydroxyapatite complex in fracture healing. The investigators hypothesized that the ossein-hydroxyapatite complex would positively impact fracture healing outcomes.The assessment covers clinical, radiological and biomechanical parameters.

CONDITIONS

Official Title

Osteogenon in Orthopedics and Traumatology

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • No contraindications to taking Osteogenon
  • Follow-up period of more than 3 months after treatment completion
  • Complete medical and radiological records available
  • Written informed consent provided
  • Not taking medications that affect bone tissue remodeling
  • Not taking medications that interact with Osteogenon
  • No other limb pathologies such as inflammatory or neurogenic conditions
  • No comorbidities that could affect bone union
Not Eligible

You will not qualify if you...

  • Age under 18 years or over 85 years
  • Hypersensitivity to the active ingredient or excipients
  • Severe renal failure or on dialysis therapy
  • Hypercalcemia or hypercalciuria
  • Calcium-based kidney stones or tissue calcifications
  • Follow-up period shorter than 3 months after treatment completion
  • Lack of informed consent or cooperation
  • Absent or incomplete medical and radiological records
  • Taking medications that affect bone remodeling or interact with Osteogenon
  • Metabolic disorders
  • Post-traumatic skeletal deformities
  • Neuromuscular disorders
  • Post-inflammatory deformities

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Clinical Hospital in Opole

Opole, Opole Voivodeship, Poland, 46-020

Actively Recruiting

Loading map...

Research Team

P

Piotr Morasiewicz, PROF

CONTACT

M

Monika Zaborska

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here